GH Guardant Health Inc

Price (delayed)

$135.39

Market cap

$13.69B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.38

Enterprise value

$14.16B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

Guardant Health's revenue has increased by 21% YoY and by 3.9% from the previous quarter
The gross profit has grown by 18% YoY
GH's equity is down by 35% QoQ but it is up by 8% YoY
The debt has surged by 58% since the previous quarter
Guardant Health's net income has decreased by 32% QoQ

Key stats

What are the main financial stats of GH
Market
Shares outstanding
101.12M
Market cap
$13.69B
Enterprise value
$14.16B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
16.05
Price to sales (P/S)
45.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
47.55
Earnings
Revenue
$297.89M
EBIT
-$329.84M
EBITDA
-$304.06M
Free cash flow
-$160.98M
Per share
EPS
-$3.38
Free cash flow per share
-$1.59
Book value per share
$8.43
Revenue per share
$2.95
TBVPS
$23.06
Balance sheet
Total assets
$2.35B
Total liabilities
$1.44B
Debt
$1.34B
Equity
$847.05M
Working capital
$1.94B
Liquidity
Debt to equity
1.59
Current ratio
21.29
Quick ratio
20.82
Net debt/EBITDA
-1.56
Margins
EBITDA margin
-102.1%
Gross margin
66.2%
Net margin
-112.7%
Operating margin
-110.1%
Efficiency
Return on assets
-18.8%
Return on equity
-30.9%
Return on invested capital
-18.7%
Return on capital employed
-14.7%
Return on sales
-110.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GH stock price

How has the Guardant Health stock price performed over time
Intraday
0.57%
1 week
-14.84%
1 month
-14.33%
1 year
61.27%
YTD
5.05%
QTD
-11.31%

Financial performance

How have Guardant Health's revenue and profit performed over time
Revenue
$297.89M
Gross profit
$197.11M
Operating income
-$327.9M
Net income
-$335.71M
Gross margin
66.2%
Net margin
-112.7%
The company's operating margin has shrunk by 188% YoY and by 24% QoQ
Guardant Health's net income has decreased by 32% QoQ
GH's operating income is down by 29% from the previous quarter
The net margin has declined by 27% since the previous quarter

Growth

What is Guardant Health's growth rate over time

Valuation

What is Guardant Health stock price valuation
P/E
N/A
P/B
16.05
P/S
45.88
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
47.55
The EPS has declined by 30% since the previous quarter
The P/B is 42% more than the last 4 quarters average of 11.3
GH's equity is down by 35% QoQ but it is up by 8% YoY
Guardant Health's revenue has increased by 21% YoY and by 3.9% from the previous quarter
The P/S is 10% above the last 4 quarters average of 41.7

Efficiency

How efficient is Guardant Health business performance
GH's ROA has dropped by 132% year-on-year and by 7% since the previous quarter
Guardant Health's ROIC has plunged by 73% YoY but it has increased by 5% from the previous quarter
The ROE has contracted by 30% from the previous quarter
The return on sales has declined by 28% since the previous quarter

Dividends

What is GH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GH.

Financial health

How did Guardant Health financials performed over time
Guardant Health's total assets is 63% more than its total liabilities
GH's current ratio has surged by 188% year-on-year but it is down by 25% since the previous quarter
Guardant Health's total assets has soared by 148% YoY and by 3.3% from the previous quarter
The debt is 59% greater than the equity
GH's debt to equity has surged by 145% since the previous quarter
The debt has surged by 58% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.